On the contrary, there were differences at baseline sampling among the groups in terms of RF-positivity, titres of ACPA as well as having a double shared epitope allele, reflecting our prior characterisation of the Karolinska risk-RA cohort showing these factors as major risks for disease progression.8 The gene discussed is PRTN3; the disease is rheumatoid arthritis.